Year 3 ยท Semester 1
Faculty of Medicine ยท Peradeniya

Cardiovascular
Pharmacology

Welcome! This is your complete guide to CV drugs โ€” taught as Dr. Amiyangoda would explain it to you from scratch. We start with why the heart needs these drugs, then learn each drug family using the exam formula.

๐Ÿ”‘

The Formula โ€” Learn This First

โš™๏ธ
Mechanism
How does it work at the molecular level?
โœ…
Uses
When do you give it? Which disease?
โš ๏ธ
Adverse Effects
What goes wrong? What to monitor?
๐Ÿšซ
Why NOT
Contraindications โ€” the exam loves this!

What You'll Master

๐Ÿฉธ

Vascular Tone Drugs

ACE inhibitors, ARBs, Calcium channel blockers, Nitrates, Catecholamines, ARNIs

Hypertension Heart failure Angina
โšก

Antiarrhythmics

Vaughan-Williams Classes 0โ€“4 with key drugs: amiodarone, lidocaine, digoxin, adenosine

AF VT SVT
๐Ÿ’ช

Inotropes

Digoxin, dobutamine, PDE inhibitors, levosimendan โ€” for failing hearts

Heart failure Shock
๐Ÿฉน

Coagulation Drugs

Anticoagulants (heparin, warfarin, DOACs) + antiplatelets + thrombolytics

DVT MI Stroke
๐Ÿ’ง

Diuretics

Loop, thiazide, Kโบ-sparing, osmotic, carbonic anhydrase inhibitors โ€” where each works in the nephron

Oedema HTN
๐Ÿฅ

Clinical Scenarios

Real patient cases โ€” choose the right drug and explain why. Exam-style practice.

Exam prep Clinical reasoning

Begin with Chapter 01: Vascular Tone

Chapter 01

Drugs Influencing Vascular Tone

Vascular tone = how tight or relaxed your blood vessels are. It determines blood pressure and how hard the heart works. These drugs are the backbone of hypertension and heart failure treatment.

๐Ÿง  The Big Picture First

Vascular smooth muscle contracts when Caยฒโบ enters โ†’ activates MLCK โ†’ myosin phosphorylation โ†’ contraction. It relaxes when cGMP/cAMP increases or Caยฒโบ is blocked.

AT-I
โ†’ ACE โ†’
AT-II
โ†’ ATโ‚ receptor โ†’
โ†‘Caยฒโบ
โ†’
VASOCONSTRICTION

๐Ÿ‘† This is what ACE inhibitors and ARBs block. Block different steps, same result: vasodilation.

Drug Families

โš™๏ธ

Mechanism

ACE inhibitors block the Angiotensin Converting Enzyme โ€” the enzyme that converts AT-I โ†’ AT-II. Less AT-II means:

  • โœ“Less vasoconstriction โ†’ lower blood pressure
  • โœ“Less aldosterone โ†’ less Naโบ/water retention
  • โœ“More bradykinin (not broken down) โ†’ extra vasodilation
  • โš That same bradykinin causes the infamous dry cough
๐Ÿ’Š

Key Drugs

Captopril
Short-acting ยท needs 2-3x daily dosing
Short
Enalapril / Ramipril / Lisinopril
Long-acting ยท once daily ยท most commonly used
Long
โœ…

Uses

Hypertension
Heart failure
Post-MI remodeling
Diabetic nephropathy
๐Ÿšซ

Adverse Effects & Why NOT

โœ•Dry cough โ€” bradykinin accumulation (switch to ARB)
โœ•Angioedema โ€” rare but life-threatening
โœ•First dose hypotension โ€” start low, go slow
โœ•Pregnancy โ€” absolutely contraindicated (fetal renal damage)
โœ•Bilateral renal artery stenosis โ€” causes AKI
โš Hyperkalaemia โ€” monitor Kโบ (don't combine with Kโบ-sparing diuretics carelessly)

๐Ÿ“Š Quick Reference: All Vascular Tone Drugs

Drug classMechanismMain useKey adverse effect / CI
ACE inhibitorsBlock ACE โ†’ โ†“AT-IIHTN, HF, post-MI, DM nephropathyDry cough, angioedema, pregnancy CI
ARBsBlock ATโ‚ receptorSame as ACEi (no cough)Pregnancy CI, hyperkalaemia
CCB (DHP)Block L-type Caยฒโบ (vascular)HTN, stable anginaAnkle oedema, flushing, reflex tachycardia
CCB (non-DHP)Block Caยฒโบ (cardiac + vascular)SVT, rate control in AFBradycardia, heart block โ€” NEVER with ฮฒ-blockers
Nitratesโ†’ NO โ†’ โ†‘cGMP โ†’ venodilationAngina (acute & prophylaxis)Nitrate tolerance, CI with PDE5 inhibitors
ARNINeprilysin inh + ARBHFrEF (replaces ACEi)CI: with ACEi (โ†‘โ†‘angioedema risk)
Chapter 02

Antiarrhythmic Drugs

Arrhythmias = abnormal heart rhythms. These drugs work by modifying ion channel activity to restore normal rhythm. The Vaughan-Williams classification is the key you need.

๐Ÿง  Why do arrhythmias happen?

Normal cardiac rhythm depends on precise ion flow. Arrhythmias occur due to: (1) Abnormal automaticity โ€” cells firing when they shouldn't, (2) Re-entry circuits โ€” impulse going round in circles, (3) Triggered activity โ€” afterdepolarisations.

Phase 0: Naโบ influx (fast) Phase 2: Caยฒโบ influx (plateau) Phase 3: Kโบ efflux (repolarisation) Phase 4: Pacemaker current (HCN)

Vaughan-Williams Classification

0

Class 0 โ€” HCN Channel Blockers

Ivabradine

Blocks the funny current (If) in the SA node โ†’ slows pacemaker rate. Reduces heart rate WITHOUT affecting contractility. Used in stable angina/heart failure when ฮฒ-blockers can't be used.

โš  CI: bradycardia, sick sinus syndrome, severe hepatic impairment
1

Class 1 โ€” Naโบ Channel Blockers

1a โ€” Intermediate
Quinidine, Disopyramide, Procainamide
Also block Kโบ โ†’ โ†‘QT (torsades risk)
1b โ€” Fast binding
Lignocaine (lidocaine), Mexiletine
IV for VT after MI. Short-acting. CNS toxicity (seizures).
1c โ€” Slow binding
Flecainide, Propafenone
Potent. CI post-MI (proarrhythmic in structural disease)
2

Class 2 โ€” Autonomic Modulators

2a: ฮฒ-blockers (Bisoprolol, Metoprolol, Carvedilol)

Block ฮฒโ‚ โ†’ โ†“SA node rate, โ†“AV conduction. Used for AF rate control, post-MI, heart failure (chronic). CI: asthma (use cardioselective), decompensated HF

2d: Digoxin ยท 2e: Adenosine

Digoxin: vagal โ†’ โ†“AV conduction, used for AF rate control. Adenosine: IV bolus โ†’ transiently blocks AV node, diagnosis/termination of SVT. Very short half-life (10s).

3

Class 3 โ€” Kโบ Channel Blockers (Amiodarone โ€” learn this well!)

Amiodarone โ€” The Drug of Multiple Actions
Naโบ block
Kโบ block
Caยฒโบ block
ฮฑ, ฮฒ block
  • โœ“ Used for SVT, VT, AF cardioversion
  • โœ“ Highly lipophilic โ†’ huge volume of distribution
  • โœ“ Half-life up to 5 MONTHS (amiodarone lasts forever!)
  • โœ• Toxicity: pulmonary fibrosis, thyroid dysfunction (both hyper/hypo), liver damage, corneal deposits, photosensitivity
  • โœ• Monitor: TFTs, LFTs, PFTs, CXR, eye exam
4

Class 4 โ€” Caยฒโบ Channel Blockers (cardiac)

Verapamil & Diltiazem โ€” block L-type Caยฒโบ in SA/AV nodes โ†’ โ†“heart rate, โ†“AV conduction. Used for SVT, AF rate control.

๐Ÿšซ NEVER combine with ฮฒ-blockers โ€” risk of complete heart block and cardiac arrest

๐Ÿ”ฌ Digoxin โ€” The Classic Drug

Mechanism

  1. Inhibits Naโบ/Kโบ-ATPase pump
  2. โ†‘ intracellular Naโบ โ†’ less Caยฒโบ expelled
  3. โ†‘ intracellular Caยฒโบ โ†’ stronger contraction (positive inotrope)
  4. Also increases vagal tone โ†’ โ†“ AV conduction (rate control in AF)

Toxicity (very important!)

  • โ€ข Nausea, vomiting, visual disturbances (yellow halos)
  • โ€ข Arrhythmias (bradycardia, heart block, VT)
  • โ€ข Hypokalaemia WORSENS toxicity (diuretics + digoxin = dangerous!)
  • โ€ข Narrow therapeutic window โ€” monitor drug levels
  • โ€ข Antidote: Digibind (anti-digoxin antibody fragments)
Chapter 03

Inotropic Drugs

These drugs increase myocardial contractility โ€” the force of the heartbeat. Used when the heart can't pump adequately (heart failure, cardiogenic shock).

๐Ÿง  One Principle: Increase Intracellular Caยฒโบ

All inotropes work by getting more Caยฒโบ available to cardiac myofilaments. They do this through different routes:

ฮฒโ‚ stimulation
โ†‘cAMP โ†’ PKA โ†’ โ†‘Caยฒโบ release
Dobutamine, adrenaline
PDE inhibition
โ†‘cAMP (less breakdown)
Milrinone, enoximone
Na/K pump block
โ†‘Naโบ โ†’ โ†‘Caยฒโบ
Digoxin

๐Ÿ’Š Dobutamine

  • Class: Synthetic catecholamine, ฮฒโ‚ agonist
  • Route: IV infusion only
  • Use: Acute decompensated heart failure, cardiogenic shock
  • Caution: Causes tachycardia and arrhythmias at high doses
  • CI: Hypertrophic obstructive cardiomyopathy

๐Ÿ’Š PDE Inhibitors (Milrinone, Enoximone)

  • Mechanism: Inhibit phosphodiesterase 3 โ†’ โ†‘cAMP โ†’ โ†‘contractility + vasodilation ("inodilatators")
  • Use: Short-term acute HF
  • Key point: Long-term use increases mortality โ€” only for bridge therapy
  • AE: Hypotension, arrhythmias

๐Ÿ’Š Levosimendan โ€” The Modern Inotrope

  • Mechanism: Caยฒโบ sensitiser โ€” makes myofilaments more sensitive to Caยฒโบ (doesn't increase Caยฒโบ itself)
  • Also: Opens K-ATP channels โ†’ vasodilation (lusitropic effect)
  • Advantage: Doesn't increase Oโ‚‚ demand as much as catecholamines
  • Use: Acute decompensated HF where dobutamine insufficient
  • Route: IV infusion, single dose (24h) โ€” effects last days due to active metabolite
  • AE: Hypotension, headache, tachycardia
Chapter 04

Drugs Used in Coagulation

Three groups: Anticoagulants (prevent clot formation), Antiplatelets (prevent platelet aggregation), Thrombolytics/Fibrinolytics (dissolve existing clots).

1. Anticoagulants

The Big 3: Heparin vs Warfarin vs DOACs

Property Heparin (UFH) LMWH (Enoxaparin) Warfarin DOACs
MechanismActivates antithrombin โ†’ inhibits IIa + XaActivates antithrombin โ†’ mainly XaInhibits Vit K epoxide reductase โ†’ โ†“II, VII, IX, XDirect Xa (rivaroxaban) or IIa (dabigatran)
RouteIV / SCSC (once daily)OralOral
MonitoringaPTTAnti-Xa (usually not needed)INR (target 2-3)Usually not needed
ReversalProtamine sulphateProtamine (partial)Vitamin K + FFP/PCCIdarucizumab (dabigatran); Andexanet alfa (Xa)
Pregnancy?โœ“ Safe (doesn't cross placenta)โœ“ Safeโœ• Teratogenic in T1, bleeding T3โœ• Avoid

2. Antiplatelet Drugs

Aspirin

Irreversibly inhibits COX-1 โ†’ โ†“TXAโ‚‚ (platelet aggregant). Low dose (75mg) for antiplatelet effect.

โœ“ ACS, stroke prevention, post-stent
โœ• Peptic ulcer, asthma (aspirin-induced)
โš  GI bleeding โ€” give with PPI

Clopidogrel (P2Y12 blocker)

Irreversibly blocks ADP receptor (P2Y12) on platelets. Prodrug โ€” requires CYP450 activation (genetic variability!).

โœ“ ACS, PCI, peripheral vascular disease
โš  Effect lasts 7-10 days (platelet lifetime)
โ„น Dual antiplatelet = aspirin + clopidogrel

GP IIb/IIIa Antagonists

Block the final common pathway of platelet aggregation (fibrinogen bridge). Most potent antiplatelets. IV only.

โœ“ High-risk PCI, NSTEMI
Abciximab, Tirofiban, Eptifibatide
โœ• Thrombocytopenia risk

3. Thrombolytics (Fibrinolytics)

These drugs activate plasminogen โ†’ plasmin โ†’ dissolves fibrin clot. They break down existing clots โ€” unlike anticoagulants which prevent new ones.

Drugs

  • Streptokinase โ€” bacterial protein, allergic reactions possible, cheaper
  • tPA (Alteplase) โ€” fibrin-specific, preferred in stroke
  • Tenecteplase โ€” single IV bolus, used in STEMI

Uses & Contraindications

โœ“ STEMI (<12h), ischaemic stroke (<4.5h), massive PE
โœ• Recent surgery/trauma, active bleeding, haemorrhagic stroke, severe HTN
Chapter 05

Diuretics & Fluid Replacement

Diuretics increase urine output by blocking Naโบ reabsorption at different points in the nephron. The key is knowing WHERE each drug acts.

๐Ÿ—บ๏ธ Where Each Drug Acts in the Nephron

PCT
Carbonic anhydrase inhibitors
Acetazolamide
Also: Osmotic (PCT + descending limb)
Loop of Henle
Loop diuretics
Furosemide, Bumetanide
Highest efficacy โ€” 20-30% Naโบ
DCT
Thiazides
HCTZ, Indapamide
Moderate โ€” 8% Naโบ
CD
Kโบ-sparing
Spironolactone, Amiloride
Weak โ€” 2% Naโบ

๐Ÿ”ต Loop Diuretics โ€” Furosemide

  • Mechanism: Block NKCC2 cotransporter in thick ascending limb
  • Effect: Also lose Caยฒโบ, Mgยฒโบ (lose everything with the loop!)
  • โœ“ Pulmonary oedema (IV โ€” fast), chronic HF, hypertension
  • โœ“ Hypercalcaemia (force Caยฒโบ excretion โ€” with IV saline)
  • โœ• Hypokalaemia, hypomagnesaemia, gout, ototoxicity (high IV dose)

๐ŸŸก Thiazides โ€” HCTZ, Indapamide

  • Mechanism: Block NCC cotransporter in DCT
  • Unique: Retain Caยฒโบ (useful in hypercalciuria/kidney stones)
  • โœ“ First-line for hypertension, CCF
  • โœ• Hypokalaemia, hyperuricaemia (gout), hyperglycaemia
  • โœ• Ineffective if GFR <30 mL/min (except metolazone)

๐ŸŸข Kโบ-sparing โ€” Spironolactone, Amiloride

  • Spironolactone: Aldosterone receptor antagonist โ†’ โ†“ENaC expression
  • Amiloride: Directly blocks ENaC channel
  • โœ“ Heart failure (spiro proven to reduce mortality), hyperaldosteronism, oedema with hypokalaemia
  • โœ• Hyperkalaemia โ€” DANGEROUS with ACE inhibitors/ARBs/Kโบ supplements
  • โš  Spironolactone: gynaecomastia (anti-androgen effect)

๐Ÿ”ฎ Electrolyte Changes Summary

DiureticKโบNaโบCaยฒโบ
Loopโ†“โ†“โ†“โ†“
Thiazideโ†“โ†“โ†‘ (retained)
Kโบ-sparingโ†‘ (retained)โ†“โ€”
Chapter 06

Clinical Scenarios

This is how the exam tests you. Read each case, choose your answer, then reveal the explanation.

Chapter 07

Flashcards Practice

Tap to flip. Master the most important facts for your exam.

1 / 0
Question ยท tap to flip
Loading...
Answer
Loading...
Chapter 08

Quick Quiz

Test your knowledge. No hints โ€” just like the real exam.